Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Oncos Therapeutics (Finland)
h-index: 25
Total citations: 2,430
Total papers: 58
Recent papers from Oncos Therapeutics (Finland)
Cancer vaccines: an update on recent achievements and prospects for cancer therapy
Clinical and Experimental Medicine · 2024
Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy
Työväentutkimus Vuosikirja · 2021
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
Journal for ImmunoTherapy of Cancer · 2021
Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer
Työväentutkimus Vuosikirja · 2021
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
Molecular Therapy — Oncolytics · 2021
A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600–Mutant Solid Tumors
Clinical Cancer Research · 2017
Synergistic anti‐tumor efficacy of immunogenic adenovirus ONCOS‐102 (Ad5/3‐D24‐GM‐CSF) and standard of care chemotherapy in preclinical mesothelioma model
International Journal of Cancer · 2016
Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
Journal for ImmunoTherapy of Cancer · 2016
Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity
Molecular Cancer Therapeutics · 2016
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
Molecular Therapy — Oncolytics · 2016
Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus
Molecular Therapy · 2015
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
OncoImmunology · 2015
Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data
Human Gene Therapy · 2015
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8⁺T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer
OncoImmunology · 2015
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM‐CSF: R esults in vitro, in rodents and in humans
International Journal of Cancer · 2015
Anti‐tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies
Veterinary and Comparative Oncology · 2014
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8⁺T-cell response, prominent infiltration of CD8⁺lymphocytes and Th1 type polarization
OncoImmunology · 2014
Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma
International Journal of Cancer · 2014
Innate Immunity to Adenovirus
Human Gene Therapy · 2014
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans
International Journal of Cancer · 2013